Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | GSK3B | P49841 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21683243 | 0.71 | POLB (0.61) | TAAR1MAPTCYP3A4HPGDMEN1 | |
| SCHEMBL3915231 | 0.69 | BCAT2 (0.45) | MAPTCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL9380718 | 0.69 | PYGM (0.43) | MAPTHPGDLMNAEGFRAURKA | |
| SCHEMBL2177925 | 0.69 | MAPT (0.69) | GSK3BMAPTPIN1L3MBTL1HPGD | |
| SCHEMBL11834671 | 0.68 | GSK3B (0.65) | GSK3BMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL11453608 | 0.67 | TAAR1 (1.00) | TAAR1MAPTCYP3A4L3MBTL1HPGD | |
| SCHEMBL11062732 | 0.67 | KMT2A (0.54) | TAAR1MAPTMEN1LMNAKMT2A | |
| SCHEMBL11453607 | 0.67 | TAAR1 (1.00) | TAAR1MAPTCYP3A4L3MBTL1HPGD | |
| SCHEMBL10814167 | 0.66 | MAPT (0.57) | GSK3BMAPTCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL16345563 | 0.66 | PIN1 (0.52) | GSK3BMAPTCYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090124593-A1 | Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their ExtraGenital Complications | MARTON MILANKOVITS | 2009-05-14 | — | — | US | disclosed |
| US-20090074839-A1 | Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications | MILANKOVITS MARTON | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124593-A1 | Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their ExtraGenital Complications | SOD1, OAT, ELANE | TAAR1 4786/4885GSK3B 3532/4885MAPT 252/4885 |
| US-20090074839-A1 | Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications | DHFR, FPGS, FOLR1 | TAAR1 4385/4885GSK3B 3831/4885MAPT 1948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.